Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Fiscal Year 'Reads Well' for Regenerative Medicine Company

The firm's final quarter and full-year results are reviewed in a Ladenburg Thalmann report. In an Aug. 30 research note, Ladenburg Thalmann analyst Jeffrey Cohen reported Mesoblast Ltd.'s (MESO:NASDAQ; MSB:ASX) financial results for Q4/19 and fiscal year 2019 (FY19)...
Streetwise Reports | September 5, 2019 |

Correction in Digital Marketing Sector Valuations Creates an Attractive Entry Point for Long-term In

(Click to read report.) Research Capital Corp. is – Initiating Coverage with a BUY Rating and Target Price of $2.20 (USD) on Logiq Inc. ( NEO: LGIQ , OTCQX: LGIQ , Forum ) Logiq’s Presence in Two Large and Growing Segments of Digital Marketing ...
Featured Submission | March 31, 2022 |

Puma Biotech Shares Up More Than 20% on Q2 Earnings and Breast Cancer Drug Sales

Shares in Puma Biotechnology are trading 20% higher today after the company released Q2/19 earnings and reported positive NERLYNX revenue growth. Biopharmaceutical company Puma Biotechnology Inc. (PBYI:NADSAQ) shares opened more than 20% higher to...
Streetwise Reports | August 14, 2019 |

Aleafia Health CEO Talks Expansion Plans and Progress

(Image via Aleafia Health. Click image to enlarge) When a business strategy works and can be expanded, the smart bet is to double down. That’s the logic in any industry, and the still-growing cannabis market is no different. That&CloseCurlyQuote...
Omri Wallach | September 27, 2019 |

Pinduoduo Stock Gains 15% After Company Reports Triple-Digit Increase in Quarterly Revenue

One year following its IPO, Chinese mobile and internet e-commerce platform company Pinduoduo Inc. reported 169% revenue growth and an 88% growth in monthly active users. Shanghai-based virtual bazaar mobile e-commerce platform operator Pinduoduo Inc. (PDD:NASDAQ) t...
Streetwise Reports | August 22, 2019 |

A Key Investment Strategy into Monetizing and Host Webinars

Investors with a keen eye to the live video conferencing technology boom, should look at the entire space beyond Zoom. Enter Personas Social Inc. ( TSX-V.PRSN , OTCMKTS: PRSNF , Forum ) – a unique company engaged in the business of offering live video conferencing ...
Dave Jackson | March 4, 2022 |

Three trends, one goal: How Bayer, MustGrow Biologics, and BASF are turning the agricultural revolut

Bayer – Stable agricultural business and pharmaceuticals provide growth momentum The Leverkusen-based group has presented its figures for 2025 and achieved the targets it set in the summer. Currency-adjusted revenue rose by 1.1% to EUR 45.6 billion, while adjusted op...
Armin Schulz | 2 days ago |

Precious Metals Reentry Time: Not Ideal but Enough for a Trade

I was looking over the charts last night (over a fine Merlot and some fava beans), trying desperately to avoid the temptation of attending that embarrassment of capitalism called PDAC. The mining conference held annually in Toronto has transformed from an industrial showc...
Streetwise Reports | March 11, 2019 |

Eton Pharma Shares Climb 20% After Firm Secures US Rights for Pediatric Kidney Disease Drug

Shares of Eton Pharmaceuticals traded higher after the company reported that it has acquired U.S. marketing rights to pediatric orphan drug Alkindi® Sprinkle from Diurnal Group Plc. Eton Pharmaceuticals Inc. (ETON:NASDAQ) , which is focused on devel...
Streetwise Reports | March 30, 2020 |

High grade drill results with visible gold at the Gold Rock Camp in Ontario

Dryden Gold Corp. isn’t just another name in Ontario’s gold belt. They’re rewriting what we thought we knew about it. Now from scratching the Elora gold system to a full kilometer, to now uncovering new zones at Gold Rock ...
Lyndsay Malchuk | August 26, 2025 |
1 2 3 4 5 6 7 8 9 10 ...